Repare Therapeutics (RPTX) Earnings Date & Reports
Get AI intraday signals
A.I. Advisor
published Earnings
RPTX is expected to report earnings to rise 10.27% to -89 cents per share on March 04
Q4'24
Est.
$-0.89
Q3'24
Beat
by $0.06
Q2'24
Beat
by $0.05
Q1'24
Beat
by $0.28
Q4'23
Missed
by $0.31
The last earnings report on November 07 showed earnings per share of -81 cents, beating the estimate of -87 cents. With 137.82K shares outstanding, the current market capitalization sits at 138.16M.
a company which engages in the research, development, and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations